{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34762115",
  "DateCompleted": {
    "Year": "2022",
    "Month": "01",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "01",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "11",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e2134142",
      "10.1001/jamanetworkopen.2021.34142"
    ],
    "Journal": {
      "ISSN": "2574-3805",
      "JournalIssue": {
        "Volume": "4",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov",
          "Day": "01"
        }
      },
      "Title": "JAMA network open",
      "ISOAbbreviation": "JAMA Netw Open"
    },
    "ArticleTitle": "Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications.",
    "Pagination": {
      "StartPage": "e2134142",
      "MedlinePgn": "e2134142"
    },
    "Abstract": {
      "AbstractText": [
        "This cross-sectional study uses national prescription data to assess whether safety communications from the US Food and Drug Administration (FDA) issued in 2017 and 2018 were associated with changes in prescriptions for codeine and hydrocodone cough and cold medications to children and adolescents."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research Center, University of Michigan Medical School, Ann Arbor."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor."
          }
        ],
        "LastName": "Chua",
        "ForeName": "Kao-Ping",
        "Initials": "KP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Markets, Public Policy, and Law, Institute for Health System Innovation and Policy, Boston University Questrom School of Business, Boston, Massachusetts."
          }
        ],
        "LastName": "Conti",
        "ForeName": "Rena M",
        "Initials": "RM"
      }
    ],
    "GrantList": [
      {
        "GrantID": "K08 DA048110",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Observational Study",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "JAMA Netw Open",
    "NlmUniqueID": "101729235",
    "ISSNLinking": "2574-3805"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "6YKS4Y3WQ7",
      "NameOfSubstance": "Hydrocodone"
    },
    {
      "RegistryNumber": "UX6OWY2V7J",
      "NameOfSubstance": "Codeine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Codeine"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Cough"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross-Sectional Studies"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Drug Prescriptions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Hydrocodone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Interrupted Time Series Analysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Longitudinal Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Practice Patterns, Physicians'"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United States"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United States Food and Drug Administration"
    }
  ],
  "CoiStatement": "<b>Conflict of Interest Disclosures:</b> Dr Chua reported receiving personal fees from the Benter Foundation and from Keystone Strategies for serving as a consultant. No other disclosures were reported."
}